152 related articles for article (PubMed ID: 12939786)
1. Non-parametric methods to predict HIV drug susceptibility phenotype from genotype.
DiRienzo AG; DeGruttola V; Larder B; Hertogs K
Stat Med; 2003 Sep; 22(17):2785-98. PubMed ID: 12939786
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 drug resistance in variants from the female genital tract and plasma.
Kemal KS; Burger H; Mayers D; Anastos K; Foley B; Kitchen C; Huggins P; Schroeder T; Picchio G; Back S; Gao W; Meyer WA; Weiser B
J Infect Dis; 2007 Feb; 195(4):535-45. PubMed ID: 17230413
[TBL] [Abstract][Full Text] [Related]
3. Drug resistance genotypes predict response to amprenavir-containing regimens in highly drug-experienced HIV-1-infected patients.
Sabin CA; Wilkins E; Murphy M; Fisher M; de Ruiter A; Easterbrook PJ; Leen C; Vlahakis E; Cane PA; Li X; Pillay D;
Antivir Ther; 2003 Aug; 8(4):301-8. PubMed ID: 14518699
[TBL] [Abstract][Full Text] [Related]
4. HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement?
Uy J; Brooks JT; Baker R; Hoffman M; Moorman A; Novak R;
Antivir Ther; 2007; 12(6):957-62. PubMed ID: 17926650
[TBL] [Abstract][Full Text] [Related]
5. Prediction of HIV-1 drug susceptibility phenotype from the viral genotype using linear regression modeling.
Vermeiren H; Van Craenenbroeck E; Alen P; Bacheler L; Picchio G; Lecocq P;
J Virol Methods; 2007 Oct; 145(1):47-55. PubMed ID: 17574687
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.
Recsky MA; Brumme ZL; Chan KJ; Wynhoven B; Yip B; Dong WW; Heath KV; Montaner JS; Levy AR; Hogg RS; Harrigan PR
J Infect Dis; 2004 Jul; 190(2):285-92. PubMed ID: 15216463
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
[TBL] [Abstract][Full Text] [Related]
8. Characterizing classes of antiretroviral drugs by genotype.
Foulkes AS; DeGruttola V
Stat Med; 2003 Aug; 22(16):2637-55. PubMed ID: 12898549
[TBL] [Abstract][Full Text] [Related]
9. [Detection of primary antiretroviral resistance in Chilean patients recently infected with human immunodeficiency virus (HIV)].
Acevedo W; Gallardo AM; Galaz J; Afani A; Cortés E
Rev Med Chil; 2007 Nov; 135(11):1406-13. PubMed ID: 18259651
[TBL] [Abstract][Full Text] [Related]
10. HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations.
Scudeller L; Torti C; Quiros-Roldan E; Patroni A; Lo Caputo S; Moretti F; Mazzotta F; Donati E; Vivarelli A; Carosi G;
J Antimicrob Chemother; 2003 Nov; 52(5):776-81. PubMed ID: 14563897
[TBL] [Abstract][Full Text] [Related]
11. Genotypic resistance tests for the management of the HIV-infected patient with non-B viral isolates.
Visco-Comandini U; Balotta C
Scand J Infect Dis Suppl; 2003; 106():75-8. PubMed ID: 15000590
[TBL] [Abstract][Full Text] [Related]
12. Primary drug resistance in antiretroviral-naïve injection drug users.
Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
[TBL] [Abstract][Full Text] [Related]
13. DR_SEQAN: a PC/Windows-based software to evaluate drug resistance using human immunodeficiency virus type 1 genotypes.
Garriga C; Menéndez-Arias L
BMC Infect Dis; 2006 Mar; 6():44. PubMed ID: 16524459
[TBL] [Abstract][Full Text] [Related]
14. Analysis of discrepancies in the interpretation of antiretroviral drug resistance results in HIV-1 infected patients of Basque Country, Spain.
Muñoz M; Carmona R; Pérez-Alvarez L; Cilla G; Suarez MD; Delgado E; Contreras G; Corral J; de Goicoetxea MJ; Medrano L; Lezaún MJ; Nájera R;
J Clin Virol; 2005 Jul; 33(3):224-9. PubMed ID: 15911444
[TBL] [Abstract][Full Text] [Related]
15. [Drug resistance in antiretroviral therapy of HIV infection].
Oette M; Häussinger D
Med Klin (Munich); 2003 Dec; 98(12):692-9. PubMed ID: 14685670
[TBL] [Abstract][Full Text] [Related]
16. The development of artificial neural networks to predict virological response to combination HIV therapy.
Larder B; Wang D; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; Monforte AD; Torti C; Zazzi M; Lane C
Antivir Ther; 2007; 12(1):15-24. PubMed ID: 17503743
[TBL] [Abstract][Full Text] [Related]
17. New insights into HIV resistance testing: nursing guidelines and implications.
Kirton CA; Kurtyka D; Sterken DJ
J Assoc Nurses AIDS Care; 2007; 18(3):74-86. PubMed ID: 17570302
[TBL] [Abstract][Full Text] [Related]
18. Resistance and replication capacity assays: clinical utility and interpretation.
Haubrich RH
Top HIV Med; 2004; 12(2):52-6. PubMed ID: 15184711
[TBL] [Abstract][Full Text] [Related]
19. Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir.
Vergani B; Cicero ML; Vigano' O; Sirianni F; Ferramosca S; Vitiello P; Di Vincenzo P; Pia De Pasquale M; Galli M; Rusconi S
J Clin Virol; 2008 Feb; 41(2):154-9. PubMed ID: 18024202
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of three computerized algorithms for prediction of antiretroviral susceptibility from HIV type 1 genotype.
Zazzi M; Romano L; Venturi G; Shafer RW; Reid C; Dal Bello F; Parolin C; Palù G; Valensin PE
J Antimicrob Chemother; 2004 Feb; 53(2):356-60. PubMed ID: 14688053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]